50 mg max: effects of CBD in France, interactions and quality control

CBD can cause drowsiness, dry mouth, digestive problems, and, in some cases, elevated liver transaminases. The most significant risk remains drug interaction, as the molecule inhibits liver enzymes used in many medications. If you are taking medication, the rule is simple: talk to your doctor or pharmacist before taking any CBD, and stop immediately if you experience any unusual effects.

In short:

Drowsiness and diarrhea remain the most frequent side effects, especially at high doses, reaching up to 30.8% respectively and leading to an elevation of liver enzymes.

CBD inhibits liver enzymes CYP3A4 and CYP2C19, which may potentiate the effect of certain medications such as anticoagulants or antiepileptics.

In cases of pregnancy, liver failure or in young people, the use of CBD must be strictly supervised or avoided to prevent serious risks.

The presence of undeclared substances, such as THC or synthetic cannabinoids, in some products contaminates serious poisonings and requires rigorous verification of analysis certificates.

The recommended precaution is to start with low doses, avoid mixing with nerve depressants, and have liver function checked if used regularly.

Vibecity

Choose a more transparent CBD

Vibe City selects CBD and hemp products based on their quality, aromatic profile, traceability and compliance.

Discover the selection

Common side effects of CBD and the role of dosage
Drug interactions: what mechanisms and treatments to monitor
Pregnancy, liver failure and other risk profiles
Why are some CBD poisonings serious?
What to do in case of an adverse effect after taking CBD?
How to concretely reduce the risks associated with CBD
What we really know, and what we still don't know
Products are inspected to minimize unpleasant surprises
Sources

Common side effects of CBD and the role of dosage

Drowsiness is the most frequently reported side effect in clinical trials involving CBD. Data from the GWEP1431 show a drowsiness incidence ranging from 23.7% to 30.8% depending on the dose administered, a figure that logically increases with the higher dosages used in a strictly medical setting.

Digestive problems then follow: diarrhea, nausea, and sometimes vomiting, especially with oils and edible products where the excipients (fractionated coconut oil, for example) can themselves irritate the digestive tract in sensitive individuals. Dry mouth and decreased appetite occur less frequently, but are still documented in pharmacovigilance reports.

These effects generally follow a dose-dependent pattern: the higher the amount of cannabidiol, the more frequent and intense the symptoms become. This is a point that many users overlook, believing that a molecule that is not strictly psychoactive cannot produce a marked dose-response effect.

Rare but real effects include:

an elevation of liver transaminases, reported in several clinical trials;
dizziness and persistent general fatigue;
rare cases of psychiatric disorders (anxiety, irritability) in sensitive profiles;
skin or allergic reactions, especially with topical forms.

Key figure: according to INRS work on the state of knowledge of cannabidiol, drowsiness and diarrhea remain the two most frequently reported adverse effects in clinical trials, with an elevation of liver enzymes observed in some patients treated with high doses.

Drug interactions: what mechanisms and treatments to monitor

Cannabidiol is metabolized by two major liver enzymes, CYP3A4 and CYP2C19. These same enzymes process a significant proportion of common medications, which explains why CBD can slow their elimination and raise their blood concentration above normal levels. The ANSM (French National Agency for Medicines and Health Products Safety) reminds the public that mixing CBD and medications is never harmless, a warning that applies to both chronic treatments and occasional use.

Certain drug classes warrant particular attention:

antiepileptics, particularly clobazam, whose active metabolite (norclobazam) can see its concentration increase sharply;
anticoagulants, whose effect can be potentiated;
immunosuppressants, where a variation in dose can have serious clinical consequences;
certain antidepressants and statins are also metabolized by these same enzymatic pathways.

The data compiled by the MSD manual on cannabidiol cite documented cases of elevated liver enzymes in patients treated concurrently with valproic acid, which necessitated dose adjustment and enhanced biological monitoring.

Pro tip: If you are taking any chronic medication, ask your doctor for a checkup before starting CBD, and then a second one after two to three weeks. This is the only way to detect a silent interaction before it becomes symptomatic.

Pregnancy, liver failure and other risk profiles

Certain situations require increased caution, or even complete avoidance of cannabidiol outside of a strict medical setting.

Pregnancy and breastfeeding: CBD crosses the placental barrier and passes into breast milk; avoiding it remains the most prudent position to protect the fetus and infant.
Liver insufficiency: The liver directly metabolizes CBD, and already compromised liver function increases the risk of toxic accumulation. Prior medical advice is essential.
Children and adolescents: outside of a supervised therapeutic framework (such as certain pharmaceutical forms prescribed in severe epilepsy), the use of CBD outside of the medical circuit is not recommended for this population.
Male fertility: animal data suggest a possible impact on sperm parameters, although human studies are still lacking to settle the question.

These precautions are in line with the WHO's position on cannabidiol), which recalls that the molecule retains psychoactive effects and justifies a level of caution comparable to that of other active substances, despite its non-narcotic status.

Why are some CBD poisonings serious?

A growing proportion of reported cases of poisoning actually have nothing to do with pure cannabidiol. ANSES has documented an increase in poisonings linked to products sold as CBD, which in fact contain other substances: hallucinations, tachycardia, intense dizziness, and sometimes convulsions have been reported since 2024.

In the majority of these cases, the identified cause was the undeclared presence of THC exceeding the legal limit, or of synthetic cannabinoids completely foreign to hemp. These substances produce effects that are far more potent and unpredictable than CBD itself, which explains the disproportionate severity of some clinical presentations.

Always check the Certificate of Analysis (COA) issued by an independent laboratory, and consult our advice for CBD-Ol sicher lagern und Laborzertifikate prüfen to ensure product quality.
Beware of abnormally low prices, which are often correlated with dubious traceability.
Keep the product packaging and label in case of an incident; they will be useful for reporting.

Key figure: Ameli points out that many commercial products do not match their labeling, with the most severe toxicity almost always stemming from a discrepancy between the actual composition and the advertised composition.

What to do in case of an adverse effect after taking CBD?

When faced with an unusual symptom, the procedure to follow remains the same regardless of the apparent severity.

Stop taking the product immediately and note the product, the exact dose and the duration of consumption.
Consult a doctor or pharmacist, bringing the product and its certificate of analysis with you if possible.
Report the adverse effect to a regional pharmacovigilance center or via the platform signalement.social-sante.gouv.fr.
Call emergency services immediately if you experience seizures, loss of consciousness, difficulty breathing, or suicidal thoughts.

A report, even for an effect deemed minor, feeds into pharmacovigilance databases like Vigilyze and helps to better understand the real risk profiles of cannabidiol.

How to concretely reduce the risks associated with CBD

Product quality remains the most crucial factor in preventing accidental poisoning, far more so than the chosen form (oil, flower, or cosmetic). Demand a certificate of analysis from an independent third-party laboratory, and avoid sellers unable to provide one.

Start with a very low dose and do not exceed 50 mg per day outside of a supervised medical setting.
Avoid any combination with alcohol, benzodiazepines or other central nervous system depressants.
Request a liver function test in case of chronic use or concomitant drug treatment.
Keep the label from each product purchased, including for CBD oils stored at home.

Pro tip: Increase the dose gradually over several days, never all at once. CBD accumulates progressively in the body, and a delayed effect of 48 to 72 hours is common in new users.

What we really know, and what we still don't know

Solid clinical evidence on CBD primarily concerns specific medical indications, requiring a prescription. For recreational or relaxation use, Inserm research reminds us that the data remains contradictory, falling far short of the promises sometimes made on packaging.

This scientific uncertainty does not negate the need for rigor regarding what is measurable: traceability, actual composition, and regulatory compliance of a product. This is where the seller's responsibility becomes crucial, by selecting verified products rather than indiscriminately offering a wide range of options. Ultimately, consulting a healthcare professional remains the best safeguard when dealing with ongoing treatment or a specific health situation.

— Julien

Products are inspected to minimize unpleasant surprises

Product selection is an important factor when product quality determines the actual risk of adverse effects.

Each product comes with verifiable traceability, a crucial point given that the majority of serious poisonings reported to health authorities stem from mislabeled products rather than CBD itself. Among the available options, Yellow Cream CBD resin appeals to those who enjoy strong flavor profiles, while Sensavea's 100% organic Anti-Stress CBD infusion and herbal tea is ideal for those seeking a gentle, non-inhaling method of consumption. More experienced users often opt for Amnesia CBD prerolls, provided they keep in mind the inhalation precautions mentioned above. If you have any doubts about a certificate of analysis or the composition of a product, the Vibecity team is available to answer any questions before you make a purchase.

Sources

French health authorities remain the reference point for monitoring the evolution of knowledge on cannabidiol:

This article provides general information and is not a substitute for professional medical advice. Consult a qualified healthcare professional about your specific situation before taking any action based on this content.